tradingkey.logo

Cooper Companies Inc

COO
78.210USD
+2.200+2.89%
Close 11/25, 16:00ETQuotes delayed by 15 min
15.55BMarket Cap
38.13P/E TTM

Cooper Companies Inc

78.210
+2.200+2.89%

More Details of Cooper Companies Inc Company

The Cooper Companies, Inc. is a global medical device company. The Company operates in two business units: CooperVision and CooperSurgical. CooperVision segment is involved in the contact lens industry. CooperSurgical segment is involved in the fertility and women's health care market through its diversified portfolio of products and services, including fertility products and services, medical devices, cryostorage (such as cord blood and cord tissue storage) and contraception. CooperVision’s products include MyDay daily disposable, MyDay daily disposable toric, MyDay Energys, MyDay multifocal, Biofinity & Biofinity XR, Biofinity Energys. CooperSurgical’s portfolio includes INSORB, Lone Star, and the Doppler Blood Flow Monitor. It also offers a suite of single-use cordless surgical retractors with an integrated multi-light-emitting diode (LED) light source and dual smoke evacuation channels, and single-use surgical suction devices with an integrated, cordless radial LED light source.

Cooper Companies Inc Info

Ticker SymbolCOO
Company nameCooper Companies Inc
IPO dateJan 21, 1983
CEOMr. Albert G. White, III
Number of employees16000
Security typeOrdinary Share
Fiscal year-endJan 21
Address6101 Bollinger Canyon Road
CitySAN RAMON
Stock exchangeNASDAQ Global Select Consolidated
CountryUnited States of America
Postal code94583
Phone19254603600
Websitehttps://www.coopercos.com/
Ticker SymbolCOO
IPO dateJan 21, 1983
CEOMr. Albert G. White, III

Company Executives of Cooper Companies Inc

Name
Name/Position
Position
Shareholding
Change
Mr. Robert S. (Bob) Weiss
Mr. Robert S. (Bob) Weiss
Independent Chairman of the Board
Independent Chairman of the Board
554.31K
+0.54%
Mr. Daniel G. (Dan) Mcbride, Esq.
Mr. Daniel G. (Dan) Mcbride, Esq.
Chief Operating Officer, Executive Vice President
Chief Operating Officer, Executive Vice President
157.62K
+1.94%
Ms. Holly R. Sheffield
Ms. Holly R. Sheffield
President - CooperSurgical, Inc
President - CooperSurgical, Inc
37.82K
+32.55%
Ms. Colleen E. Jay
Ms. Colleen E. Jay
Independent Director
Independent Director
29.52K
+10.15%
Ms. Teresa Smith Madden
Ms. Teresa Smith Madden
Independent Director
Independent Director
12.01K
+29.30%
Dr. Maria Rivas, M.D.
Dr. Maria Rivas, M.D.
Independent Director
Independent Director
10.14K
+36.67%
Ms. Cynthia L. (Cindy) Lucchese, CPA
Ms. Cynthia L. (Cindy) Lucchese, CPA
Independent Director
Independent Director
7.66K
+55.08%
Mr. Agostino Ricupati
Mr. Agostino Ricupati
Senior Vice President - Finance and Tax, Chief Accounting Officer
Senior Vice President - Finance and Tax, Chief Accounting Officer
7.51K
+15.72%
Mr. Lawrence Erik Kurzius
Mr. Lawrence Erik Kurzius
Independent Director
Independent Director
5.78K
+52.95%
Mr. Nicholas S. Khadder, J.D.
Mr. Nicholas S. Khadder, J.D.
Vice President, General Counsel, Corporate Secretary
Vice President, General Counsel, Corporate Secretary
2.14K
+320.67%
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Robert S. (Bob) Weiss
Mr. Robert S. (Bob) Weiss
Independent Chairman of the Board
Independent Chairman of the Board
554.31K
+0.54%
Mr. Daniel G. (Dan) Mcbride, Esq.
Mr. Daniel G. (Dan) Mcbride, Esq.
Chief Operating Officer, Executive Vice President
Chief Operating Officer, Executive Vice President
157.62K
+1.94%
Ms. Holly R. Sheffield
Ms. Holly R. Sheffield
President - CooperSurgical, Inc
President - CooperSurgical, Inc
37.82K
+32.55%
Ms. Colleen E. Jay
Ms. Colleen E. Jay
Independent Director
Independent Director
29.52K
+10.15%
Ms. Teresa Smith Madden
Ms. Teresa Smith Madden
Independent Director
Independent Director
12.01K
+29.30%
Dr. Maria Rivas, M.D.
Dr. Maria Rivas, M.D.
Independent Director
Independent Director
10.14K
+36.67%

Revenue Breakdown

Currency: USDUpdated: Mon, Oct 6
Currency: USDUpdated: Mon, Oct 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
Sphere, other
359.60M
33.91%
Toric and multifocal
358.80M
33.84%
Office and surgical procedures
204.80M
19.32%
Fertility
137.10M
12.93%
By RegionUSD
Name
Revenue
Proportion
United States
516.20M
48.68%
Europe
343.10M
32.36%
Rest of the World
201.00M
18.96%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Sphere, other
359.60M
33.91%
Toric and multifocal
358.80M
33.84%
Office and surgical procedures
204.80M
19.32%
Fertility
137.10M
12.93%

Shareholding Stats

Updated: Mon, Nov 17
Updated: Mon, Nov 17
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
The Vanguard Group, Inc.
12.01%
Capital World Investors
5.31%
BlackRock Institutional Trust Company, N.A.
4.95%
T. Rowe Price Investment Management, Inc.
4.94%
State Street Investment Management (US)
4.32%
Other
68.47%
Shareholders
Shareholders
Proportion
The Vanguard Group, Inc.
12.01%
Capital World Investors
5.31%
BlackRock Institutional Trust Company, N.A.
4.95%
T. Rowe Price Investment Management, Inc.
4.94%
State Street Investment Management (US)
4.32%
Other
68.47%
Shareholder Types
Shareholders
Proportion
Investment Advisor
57.68%
Investment Advisor/Hedge Fund
34.51%
Hedge Fund
6.13%
Research Firm
3.90%
Bank and Trust
1.26%
Pension Fund
1.25%
Family Office
0.91%
Family Office
0.91%
Family Office
0.69%

Institutional Shareholding

Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
1369
206.06M
103.65%
-4.26M
2025Q2
1372
201.42M
100.96%
-3.35M
2025Q1
1397
205.30M
102.90%
-1.63M
2024Q4
1374
201.70M
100.87%
-2.46M
2024Q3
1342
195.61M
98.22%
-9.91M
2024Q2
1326
197.76M
99.32%
-3.35M
2024Q1
1322
193.10M
97.16%
-14.36M
2023Q4
1307
199.91M
100.91%
-7.12M
2023Q3
1298
198.32M
100.11%
-6.24M
2023Q2
1283
197.41M
99.69%
-11.80M
View more

Shareholder Activity

Name
Shares Held
Proportion
Change
Chg %
Date
The Vanguard Group, Inc.
24.16M
12.15%
+419.27K
+1.77%
Jun 30, 2025
Capital World Investors
8.39M
4.22%
+645.79K
+8.34%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
9.76M
4.91%
-120.78K
-1.22%
Jun 30, 2025
T. Rowe Price Investment Management, Inc.
7.38M
3.71%
+106.52K
+1.46%
Jun 30, 2025
State Street Investment Management (US)
8.66M
4.36%
+104.91K
+1.23%
Jun 30, 2025
Kayne Anderson Rudnick Investment Management, LLC
7.85M
3.95%
-130.44K
-1.63%
Jun 30, 2025
Geode Capital Management, L.L.C.
5.21M
2.62%
+127.91K
+2.52%
Jun 30, 2025
Sustainable Growth Advisers, LP
3.39M
1.7%
+2.79M
+466.43%
Jun 30, 2025
Neuberger Berman, LLC
5.06M
2.55%
+1.46M
+40.32%
Jun 30, 2025
View more

Related ETFs

Updated: Thu, Nov 6
Updated: Thu, Nov 6
Name
Proportion
Themes US R&D Champions ETF
1.97%
Invesco Bloomberg Pricing Power ETF
1.85%
First Trust Indxx Medical Devices ETF
1.7%
Invesco S&P 500 Equal Weight Health Care ETF
1.67%
SPDR S&P Health Care Equipment ETF
1.66%
Motley Fool Mid-Cap Growth ETF
1.5%
Congress SMid Growth ETF
1.39%
Invesco ESG NASDAQ Next Gen 100 ETF
1.05%
Pacer US Export Leaders ETF
1.04%
Capital Group US Small and Mid Cap ETF
0.84%
View more
Themes US R&D Champions ETF
Proportion1.97%
Invesco Bloomberg Pricing Power ETF
Proportion1.85%
First Trust Indxx Medical Devices ETF
Proportion1.7%
Invesco S&P 500 Equal Weight Health Care ETF
Proportion1.67%
SPDR S&P Health Care Equipment ETF
Proportion1.66%
Motley Fool Mid-Cap Growth ETF
Proportion1.5%
Congress SMid Growth ETF
Proportion1.39%
Invesco ESG NASDAQ Next Gen 100 ETF
Proportion1.05%
Pacer US Export Leaders ETF
Proportion1.04%
Capital Group US Small and Mid Cap ETF
Proportion0.84%

Dividend

A total of 12.00M USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
Jul 12, 2023
COO.NB Interim Cash Dividend of gross USD 0.03 paid on Aug 11, 2023 going ex on Jul 26, 2023
Jul 27, 2023
Aug 11, 2023
Jul 26, 2023
Dec 14, 2022
COO.NB Final Cash Dividend of gross USD 0.03 paid on Feb 10, 2023 going ex on Jan 20, 2023
Jan 23, 2023
Feb 10, 2023
Jan 20, 2023
Jul 13, 2022
COO.NB Interim Cash Dividend of gross USD 0.03 paid on Aug 11, 2022 going ex on Jul 26, 2022
Jul 27, 2022
Aug 11, 2022
Jul 26, 2022
Dec 08, 2021
COO.NB Final Cash Dividend of gross USD 0.03 paid on Feb 09, 2022 going ex on Jan 20, 2022
Jan 21, 2022
Feb 09, 2022
Jan 20, 2022
Jul 14, 2021
COO.NB Interim Cash Dividend of gross USD 0.03 paid on Aug 11, 2021 going ex on Jul 26, 2021
Jul 27, 2021
Aug 11, 2021
Jul 26, 2021
Jan 07, 2021
COO.NB Final Cash Dividend of gross USD 0.03 paid on Feb 09, 2021 going ex on Jan 21, 2021
Jan 22, 2021
Feb 09, 2021
Jan 21, 2021
Jul 09, 2020
COO.NB Interim Cash Dividend of gross USD 0.03 paid on Aug 07, 2020 going ex on Jul 22, 2020
Jul 23, 2020
Aug 07, 2020
Jul 22, 2020
Jan 07, 2020
COO.NB Final Cash Dividend of gross USD 0.03 paid on Feb 10, 2020 going ex on Jan 22, 2020
Jan 23, 2020
Feb 10, 2020
Jan 22, 2020

Stock Split

Date
Type
Ratio
Dec 07, 2023
Split
1→4
Date
Type
Ratio
Dec 07, 2023
Split
1→4

FAQs

Who are the top five shareholders of Cooper Companies Inc?

The top five shareholders of Cooper Companies Inc are:
The Vanguard Group, Inc. holds 24.16M shares, accounting for 12.15% of the total shares.
Capital World Investors holds 8.39M shares, accounting for 4.22% of the total shares.
BlackRock Institutional Trust Company, N.A. holds 9.76M shares, accounting for 4.91% of the total shares.
T. Rowe Price Investment Management, Inc. holds 7.38M shares, accounting for 3.71% of the total shares.
State Street Investment Management (US) holds 8.66M shares, accounting for 4.36% of the total shares.

What are the top three shareholder types of Cooper Companies Inc?

The top three shareholder types of Cooper Companies Inc are:
The Vanguard Group, Inc.
Capital World Investors
BlackRock Institutional Trust Company, N.A.

How many institutions hold shares of Cooper Companies Inc (COO)?

As of 2025Q3, 1369 institutions hold shares of Cooper Companies Inc, with a combined market value of approximately 206.06M, accounting for 103.65% of the total shares. Compared to 2025Q2, institutional shareholding has increased by 2.69%.

What is the biggest source of revenue for Cooper Companies Inc?

In FY2025Q3, the Sphere, other business generated the highest revenue for Cooper Companies Inc, amounting to 359.60M and accounting for 33.91% of total revenue.
KeyAI